Phase I/II trial of weekly bortezomib with lenalidomide and dexamethasone in first relapse or primary refractory myeloma

Annemiek Broijl, Marie-José Kersten, Wendimagegn Ghidey Alemayehu, Mark-David Levin, Okke de Weerdt, Edo Vellenga, Ellen Meijer, Shulamit Wittebol, Bea C. Tanis, Petra B. Cornelisse, Marian Stevens-Kroef, Gerard M. J. Bos, Pierre W. Wijermans, Henk Lokhorst, Pieter Sonneveld

Research output: Contribution to journalComment/Letter to the editorAcademic

4 Citations (Scopus)
Original languageEnglish
Pages (from-to)e149-e152
Issue number4
Publication statusPublished - Apr 2016


  • VRD
  • escalated dose
  • first relapse
  • multiple myeloma

Cite this